Uta Griesenbach, Eric W.F.W. Alton, Department of Gene Therapy, Faculty of Medicine ... proof-of-principle for gene transfer into the cystic fibrosis (CF) lung. It is currently unknown whether ...
Gene therapy for CF and α1-ATD seeks to produce ... for the damaged originals and revert the disease process. Cystic fibrosis (CF), α1-antitrypsin deficiency (α1-ATD), and surfactant protein ...
"4DMT reveals positive interim Phase I/II data for cystic fibrosis gene therapy" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...
New breakthroughs in gene editing mean that cures for genetic diseases such as cystic fibrosis could be developed in the near ...
The FDA has approved Vertex’s Alyftrek, a once-daily triple combination for the treatment of cystic fibrosis in people 6 years and older who have mutations that are amenable to the therapy ...
Analyst Matthew Caufield of H.C. Wainwright reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report), retaining the price ...
Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB ... In respiratory, KB407 is being investigated for cystic fibrosis, the most common inherited genetic disorder in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback